Rhythm Pharmaceuticals, Inc. - Common Stock (RYTM) stock analysis
RYTM · Rhythm Pharmaceuticals, Inc. - Common Stock
Latest recorded price: USD 116.61
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: free cash flow margin -61.5%. The model flags 1 risk signal for this company (1 high severity).